EKF Diagnostics Holdings ( (GB:EKF) ) has shared an update.
EKF Diagnostics Holdings plc has announced the purchase of 200,000 of its ordinary shares at a price of 21 pence per share, which will be held in treasury. This share buyback is part of the company’s strategy to manage its capital structure and maintain the aggregate indirect beneficial interest of Mr. Mills, a non-executive director, at approximately the same level, ensuring it does not exceed 30% of the total voting rights. This move may impact the company’s market positioning by potentially increasing shareholder value and stabilizing its share price.
More about EKF Diagnostics Holdings
EKF Diagnostics Holdings plc is an AIM-listed global diagnostics business focused on providing point-of-care analyzers in hematology and diabetes, as well as life sciences services that include the specialist manufacture of enzymes and custom products for diagnostic, food, and industrial applications. The company is headquartered in Penarth, near Cardiff, and operates five manufacturing sites across the US and Germany, selling its products in over 120 countries worldwide.
YTD Price Performance: -22.22%
Average Trading Volume: 568,192
Technical Sentiment Signal: Buy
Current Market Cap: £94.82M
See more data about EKF stock on TipRanks’ Stock Analysis page.